Pediatric Myelodysplastic Syndrome with SF3B1 Mutation.

Abstract

Objectives: Patients with Fanconi Anemia (FA) have an increased risk of developing myeloid malignancies, which often precede the diagnosis of FA. We describe a patient with non-specific clinical findings diagnosed with myelodysplastic syndrome (MDS) at 17 years of age. A pathogenic SF3B1 alteration was identified and prompted evaluation for a bone marrow failure syndrome. Chromosomal breakage testing demonstrated an increase in breakage and radial formation; a targeted FA molecular panel identified variants of unknown significance in FANCB and FANCM. To date, reports of pediatric patients, with or without a co-morbid diagnosis of FA, diagnosed with MDS with SF3B1 alteration are rare. We describe a patient with FA diagnosed with MDS with ring sideroblasts and multilineage dysplasia (MDS-RS-MLD, WHO revised 4th edition) with an associated SF3B1 alteration and discuss the new classifications of this entity. In addition, as the knowledge around FA grows, so too does the knowledge about genes associated with FA. We present a novel variant of unknown significance in FANCB, to add to the growing body of literature about genetic alterations identified in individuals with a clinical picture most in keeping with FA.